{"id":446517,"title":"Notice to stakeholders: Requests to the Special Access Program (SAP) involving psychedelic-assisted psychotherapy - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T12:08:50.894000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/requests-special-access-program-psychedelic-assisted-psychotherapy.html?wbdisable=false","snippet":"Notice to stakeholders: Requests to the Special Access Program (SAP) involving psychedelic-assisted psychotherapy February 27, 2023 Our file number: 23-100122-763 On this page Purpose Background Process for making an SAP request Contact us Purpose Health Canada recognizes the…","rawSnapshotUrl":"/api/snapshots/raw/446517","browseUrl":"https://replay.healtharchive.ca/job-6/20260103120850/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/requests-special-access-program-psychedelic-assisted-psychotherapy.html?wbdisable=false#ha_snapshot=446517","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}